Mack Nelson Haynes

Array ( [id] => 3938183 [patent_doc_number] => 05997870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Isolated peptides which bind to HLA-B44 Molecules' [patent_app_type] => 1 [patent_app_number] => 8/373636 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 8210 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/997/05997870.pdf [firstpage_image] =>[orig_patent_app_number] => 373636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784394 [patent_doc_number] => 05840513 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Antibodies directed to pagC peptides for the detection of salmonellae' [patent_app_type] => 1 [patent_app_number] => 8/372197 [patent_app_country] => US [patent_app_date] => 1995-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 5538 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840513.pdf [firstpage_image] =>[orig_patent_app_number] => 372197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038432 [patent_doc_number] => 05874088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Deletion mutants of cholera vaccines expressing heterologous antigens' [patent_app_type] => 1 [patent_app_number] => 8/367115 [patent_app_country] => US [patent_app_date] => 1995-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 15022 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874088.pdf [firstpage_image] =>[orig_patent_app_number] => 367115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920835 [patent_doc_number] => 05876716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Method of using an antibody to the TN antigen for the inhibition of HIV infection' [patent_app_type] => 1 [patent_app_number] => 8/368383 [patent_app_country] => US [patent_app_date] => 1994-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 7151 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876716.pdf [firstpage_image] =>[orig_patent_app_number] => 368383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872941 [patent_doc_number] => 05804194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Vaccines containing a salmonella bacteria attenuated by mutation of the htra gene' [patent_app_type] => 1 [patent_app_number] => 8/350741 [patent_app_country] => US [patent_app_date] => 1994-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4582 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804194.pdf [firstpage_image] =>[orig_patent_app_number] => 350741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770427 [patent_doc_number] => 05817317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Clostridium perfringens vaccines' [patent_app_type] => 1 [patent_app_number] => 8/341538 [patent_app_country] => US [patent_app_date] => 1994-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5041 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817317.pdf [firstpage_image] =>[orig_patent_app_number] => 341538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700627 [patent_doc_number] => 05674735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'DNA encoding the EHV-4 gH or gC glycoprotein' [patent_app_type] => 1 [patent_app_number] => 8/344536 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 5894 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674735.pdf [firstpage_image] =>[orig_patent_app_number] => 344536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622444 [patent_doc_number] => 05614611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils' [patent_app_type] => 1 [patent_app_number] => 8/328842 [patent_app_country] => US [patent_app_date] => 1994-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13186 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614611.pdf [firstpage_image] =>[orig_patent_app_number] => 328842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991613 [patent_doc_number] => 05922326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Attenuated respiratory syncytial virus vaccine compositions' [patent_app_type] => 1 [patent_app_number] => 8/327263 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23825 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922326.pdf [firstpage_image] =>[orig_patent_app_number] => 327263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781380 [patent_doc_number] => 05840312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein' [patent_app_type] => 1 [patent_app_number] => 8/325647 [patent_app_country] => US [patent_app_date] => 1994-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 7210 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840312.pdf [firstpage_image] =>[orig_patent_app_number] => 325647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3570047 [patent_doc_number] => 05538866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Prostate-specific membrane antigen' [patent_app_type] => 1 [patent_app_number] => 8/325553 [patent_app_country] => US [patent_app_date] => 1994-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 30 [patent_no_of_words] => 15986 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538866.pdf [firstpage_image] =>[orig_patent_app_number] => 325553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4019067 [patent_doc_number] => 05882652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Empty canine parvovirus capsids having CPV recombinant VP2 and vaccines having such capsids' [patent_app_type] => 1 [patent_app_number] => 8/317785 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6408 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882652.pdf [firstpage_image] =>[orig_patent_app_number] => 317785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3812581 [patent_doc_number] => 05789233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'DNA encoding an Eimekia 50 KD antigen' [patent_app_type] => 1 [patent_app_number] => 8/310357 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15445 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789233.pdf [firstpage_image] =>[orig_patent_app_number] => 310357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693692 [patent_doc_number] => 05661006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'DNA encoding the Canine coronavirus spike protein' [patent_app_type] => 1 [patent_app_number] => 8/308872 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9943 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661006.pdf [firstpage_image] =>[orig_patent_app_number] => 308872 [rel_patent_id] =>[rel_patent_doc_number] =>)